Clinically, lower circulating levels of Nrg4 are negatively correlated with body mass index (BMI), waist circumference, and the presence of metabolic syndrome, supporting its potential role as both a biomarker and therapeutic target in obesity treatment [84]. The gene discussed is NRG4; the disease is obesity due to melanocortin 4 receptor deficiency.